Will the FDA approve intismeran autogene (V940/mRNA-4157)?
intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanomaScience
Will the FDA approve intismeran autogene (V940/mRNA-4157)?
intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanomaScience
Kalshi Aktiv 5 Märkte·95¢ Will the FDA approve intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma before Jul 1, 2028?·$0 Gesamtvolumen·-- Liquidität·-- OI
6mo·Apr 8, 2027
Verfolge deine Prognosemarkt-Positionen
Verbinde dein Kalshi-Konto, um deine Kontrakte, dein G/V und Abrechnungen zu verfolgen.
Weiter Spread
Keine Chartdaten verfügbar
Märkte
5(V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment completely resected stage IIB-IV melanoma before Jul 2028
$0 vol
(V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment completely resected stage IIB-IV melanoma before Jan 2028
$0 vol
(V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment completely resected stage IIB-IV melanoma before Oct 2027
$0 vol
(V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment completely resected stage IIB-IV melanoma before Jul 2027
$0 vol
(V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment completely resected stage IIB-IV melanoma before Apr 2027
$0 vol
(V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment completely resected stage IIB-IV melanoma before Jul 2028
Keine Orderbuchdaten verfügbar
If the FDA approves intismeran autogene (V940/mRNA-4157) with pembrolizumab (KEYTRUDA) for adjuvant treatment of completely resected stage IIB-IV melanoma for marketing before Apr 1, 2027, then the market resolves to Yes.
Verfolge deine Kalshi-Wetten — und alles andere
Erstelle ein kostenloses Portfolio mit deinen Kalshi-Positionen, Gewinn & Verlust und Live-Quoten. Füge dann Krypto-Wallets, Börsen, DeFi und mehr hinzu — alles an einem Ort.
Polymarket
Kalshi
50+ Chains
40+ Exchanges
DeFi
NFTs
16K+ Tokens
100% kostenlos· Nur Lesezugriff· Verschlüsselt